An aberrantDRB4 null gene transcript is found that could encode a novel HLA-DR chain

1990 ◽  
Vol 31 (2) ◽  
pp. 112-117 ◽  
Author(s):  
Vivien R. Sutton ◽  
Robert W. Knowles
Keyword(s):  
Gene Transcript ◽  
Null Gene ◽  
Hla Dr

Alendronate Stimulates Expression of Functional Surface Molecules ICAM-1, HLA-DR, and B7-2 on Human Monocytes

2006 ◽  
Vol 15 (03) ◽  
pp. 188-196
Author(s):  
S. Brosch ◽  
M. Shehata ◽  
G. Hofbauer ◽  
M. Peterlik ◽  
P. Pietschmann
Keyword(s):  
Human Monocytes ◽  
Functional Surface ◽  
Surface Molecules ◽  
Hla Dr

SDS-stable HLA DR dimers up-production by covalently linked complement C3B fragment

1997 ◽  
Vol 56 (1-3) ◽  
pp. 237
Author(s):  
V Serra
Keyword(s):  
Hla Dr ◽  
Covalently Linked

Age-dependent differences in postoperative HLA-DR expression in cardiac surgery patients

2011 ◽  
Vol 59 (S 01) ◽  
Author(s):  
K Lazouski ◽  
A Zittermann ◽  
M Schmidt ◽  
J Gummert ◽  
J Börgermann
Keyword(s):  
Cardiac Surgery ◽  
Hla Dr ◽  
Age Dependent

Relationship of Major Histocompatibility Complex Class II Genes to Inhibitor Antibody Formation in Hemophilia A

1990 ◽  
Vol 64 (04) ◽  
pp. 564-568 ◽  
Author(s):  
Lloyd E Lippert ◽  
Lyman Mc A Fisher ◽  
Lawrence B Schook
Keyword(s):  
Major Histocompatibility Complex ◽  
Factor Viii ◽  
Antibody Formation ◽  
Rflp Analysis ◽  
Class Ii ◽  
Major Histocompatibility ◽  
Odds Ratios ◽  
Inhibitory Antibody ◽  
Histocompatibility Complex ◽  
Hla Dr

SummaryApproximately 14% of transfused hemophiliacs develop an anti-factor VIII inhibitory antibody which specifically neutralizes factor VIII procoagulant activity. In this study an association of the major histocompatibility complex (MHC) with inhibitor antibody formation was evaluated by restriction fragment length polymorphism (RFLP) analysis using BamHI, EcoRI, HindII, PstI, PvuII and TaqI digested genomic DNA probed with DP beta, DQ alpha, DQ beta and DR beta class II MHC gene probes. The RFLP patterns for 16 non-inhibitor and 11 inhibitor hemophiliac patients were analyzed. These 24 enzyme:probe combinations generated 231 fragments. Fifteen (15) fragments associated with the inhibitor phenotype; odds ratios ranged from 5.1 to 45 and lower bounds of 95% confidence intervals were > 1.000 for all 15 fragments. Five (5) fragments associated with non-inhibitors, with odds ratios ranging from 6.4 to 51.7. This report establishes a MHC related genetic basis for the inhibitor phenotype. No statistically significant differences in the distribution of serologically defined HLA-DR phenotypes were observed between the inhibitor and non-inhibitor groups.

Quantitative Messung der monozytären HLA-DR Expression bei gesunden Neugeborenen

2004 ◽  
Vol 208 (S 1) ◽  
Author(s):  
T Spreemann ◽  
B Spring ◽  
CF Poets ◽  
T Orlikowsky
Keyword(s):  
Hla Dr

Effects of thyrocytes on intrathyroidal HLA-DR+ lymphocytes and CD94+ NK cells in vitro differ depending on thyroid disease

2005 ◽  
Vol 113 (S 1) ◽  
Author(s):  
M Penna-Martinez ◽  
K Andric ◽  
RA Wahl ◽  
KH Usadel ◽  
PM Schumm-Draeger
Keyword(s):  
Nk Cells ◽  
Thyroid Disease ◽  
Hla Dr

Increased numbers of Langerhans cell and expression of HLA-Dr antigen in the giant papilla of patients with giant papillary conjunctivitis

1996 ◽  
Vol 10 (1) ◽  
pp. 18 ◽  
Author(s):  
Tae Hoon Choi ◽  
Myung Kyoo Ko ◽  
Joon Kiu Choe
Keyword(s):  
Langerhans Cell ◽  
Hla Dr ◽  
Giant Papillary Conjunctivitis

HLA-DR antigen frequencies in a North Indian type I diabetic population

Diabetes ◽  
1985 ◽  
Vol 34 (6) ◽  
pp. 565-567 ◽  
Author(s):  
E. Bhatia ◽  
N. K. Mehra ◽  
V. Taneja ◽  
M. C. Vaidya ◽  
M. M. Ahuja
Keyword(s):  
Type I ◽  
Hla Dr ◽  
Diabetic Population

HLA-DR associations in black type I diabetics in Nigeria. Further support for models of inheritance

Diabetes ◽  
1986 ◽  
Vol 35 (5) ◽  
pp. 583-589 ◽  
Author(s):  
M. J. MacDonald ◽  
O. O. Famuyiwa ◽  
I. A. Nwabuebo ◽  
A. F. Bella ◽  
T. A. Junaid ◽  
...  
Keyword(s):  
Type I ◽  
Hla Dr
Sign in / Sign up

Export Citation Format

Share Document